Biotech for a Future-proof Planet 2026
Hollandbio, Met korting01/10/26
Get ready for the fifth edition of hollandbio’s Biotech for a Sustainable Future – now renamed Biotech for a Future-proof Planet 2026 – on Thursday, 1 October 2026, in Woerden. This annual event has become the go-to meeting place for everyone working on biotech solutions in plants, food, and materials.
This year, entrepreneurs, policy makers, investors and stakeholders will come together to explore the financing landscape for future-proof biotech solutions. From venture capital and corporate venturing to public funding, this session will discuss what it takes to turn promising innovations into real-world impact.
Date: Thursday, October 1, 2026
Time: 13:00 – 17:30
Location: Kas Meeting Eventlocatie, De Bleek 13, 3447 GV Woerden
Registration: Biotech professionals from industry and academia can register using the button in the top right corner or via this link.
- Free admission for members of hollandbio and/or NBV.
- €35 entrance fee for non-members
Program:
13:00 – 13:30: Registration, coffee & tea
13:30 – 16:00: Plenary program moderated by hollandbio’s Wieteke, featuring keynote presentations and a panel discussion with:
- Willemijn van der Elst (instead of Victor Meijer), Invest-NL
- Guillaume Baxter, Sofinnova
- Ferdinand Los, Hudson River Biotechnology
16:00 – 17:30: networking drinks & bites
Speakers:
Willemijn van der Elst, Investment Manager Agrifood at Invest-NL
Part of the agrifood team, which invests in startups and scale-ups with a focus on new technologies in alternative proteins, functional ingredients, and technologies enabling a transition to a (more) regenerative agriculture.
Guillaume Baxter, Partner at Sofinnova
Focuses on investments in industrial biotechnology, food, and agbiotech. He will share about his work backing entrepreneurs that use science and innovation to reinvent traditional industries and advance the transition to a more sustainable economy.
Ferdinand Los, CEO of Hudson River Biotechnology
Successfully raised funding in 2024. He will share about the role different types of investors can play in a biotech company’s growth, and how increasing acceptance of new genomic techniques (NGTs) is opening up new opportunities for scaling his innovation.
Want to learn what it takes to fund the next generation of biotech solutions? Secure your ticket today!